PLX PHARMA WKN: A2DMUN ISIN: US72942A1079 Kürzel: 1D5A Forum: Aktien Thema: Hauptdiskussion

PLx Pharma Inc. Announces New Scientific Data Available Evaluating the Pharmacologic Profile of FDA-Approved VAZALORE 81 mg Liquid-Filled Aspirin Capsules https://finance.yahoo.com/news/plx-pharma-inc-announces-scientific-135000021.html -- VAZALORE 81 mg shows fast bioavailability, absorption, and platelet inhibition -- -- VAZALORE 81 mg has pharmacokinetic and pharmacodynamic profiles consistent with VAZALORE 325 mg -- ...

https://www.analystratings.com/articles/jmp-securities-remains-a-buy-on-plx-pharma-plxp/

PLx Pharma Inc. Provides VAZALORE Launch Update https://www.globenewswire.com/news-release/2021/10/29/2323515/0/en/PLx-Pharma-Inc-Provides-VAZALORE-Launch-Update.html -- Supplied VAZALORE to 30,000+ stores nationwide and e-commerce sites -- -- Launch in line with expectations and exceptionally positive feedback from consumers and healthcare professionals received -- -- Third quarter 2021 earnings and business update conference call scheduled for November 12th -- ...

https://www.infrastructurene.ws/2021/10/26/ischemic-cerebral-stroke-market-2021-major-eminent-key-players-growing-with-tremendous-speed-touching-new-industry-heights-forecast-by-2027/

https://ir.plxpharma.com/news-releases/news-release-details/plx-pharma-inc-issues-statement-recent-usptf-recommendations

https://www.globenewswire.com/news-release/2021/10/14/2314570/0/en/PLx-Pharma-Inc-Issues-Statement-on-Recent-USPTF-Recommendations-on-Aspirin-Therapy-for-Primary-Prevention-of-Cardiovascular-Disease-PLx-s-VAZALORE-Specifically-Indicated-for-Second.html PLx Pharma, Inc. Issues Statement on Recent USPTF Recommendations on Aspirin Therapy for Primary Prevention of Cardiovascular Disease; PLx’s VAZALORE Specifically Indicated for Secondary Prevention Aspirin remains an established practice for the prevention of another heart attack or clot-related stroke ...

Oh, da war ich wohl etwas zu langsam 🙃

Könnte damit zusammen hängen: Kehrtwende in US-Medizin: US-Gremium empfiehlt Aspirin nicht mehr vorbeugend https://www.n-tv.de/wissen/US-Gremium-empfiehlt-Aspirin-nicht-mehr-vorbeugend-article22863272.html https://www.washingtonpost.com/lifestyle/2021/10/12/low-dose-aspirin-heart-attack-stroke/

Grund ist wohl der folgende Artikel,andere News gab es nicht. Ich halte das für eine Überreaktion. Spannend wird's wenn die nächsten Zahlen veröffentlicht werden: https://www.washingtonpost.com/lifestyle/2021/10/12/low-dose-aspirin-heart-attack-stroke/

Was ist los?

https://www.barrons.com/articles/new-aspirin-plx-mucinix-51632161197

👍Danke

Der Artikel gibt eine gute Zusammenfassung zu PLXP: Finanzen, Pipeline, Perspektive: https://seekingalpha.com/article/4455733-plx-pharma-first-commercial-launch-makes-it-attractive

https://ir.plxpharma.com/news-releases/news-release-details/plx-pharma-inc-present-upcoming-virtual-healthcare-industry

https://www.moneyshow.com/articles/dailyguru-57244/

https://www.webmd.com/men/features/aspirin-day-not